56
Participants
Start Date
November 30, 2004
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
BN80927
Administered over 30 minutes in the vein with a fixed infusion rate once every 3 weeks. Each patient could participate in a maximum of 10 continuous cycles, equivalent to 30 weeks treatment.
Centre Paul Papin, Angers
Centre Eugene Marquis, Rennes
Centre Rene Huguenin, Saint-Cloud
Lead Sponsor
Ipsen
INDUSTRY